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Abstract 
Background: The molecular clock hypothesis that genes or proteins evolve at a constant rate is a key tool to reveal 
phylogenetic relationships among species. Using the molecular clock, we can trace an infection back to transmission 
using HIV-1 sequences from a single time point. Whether or not a strict molecular clock applies to HIV-1’s early evolu-
tion in the presence of immune selection has not yet been fully examined.
Results: We identified molecular clock signatures from 1587 previously published HIV-1 full envelope gene 
sequences obtained since acute infection in 15 subjects. Each subject’s sequence diversity linearly increased during 
the first 150 days post infection, with rates ranging from 1.54× 10−5 to 3.91× 10−5 with a mean of 2.69× 10−5 per 
base per day. The rate of diversification for 12 out of the 15 subjects was comparable to the neutral evolution rate. 
While temporal diversification was consistent with evolution patterns in the absence of selection, mutations from 
the founder virus were highly clustered on statistically identified selection sites, which diversified more than 65 times 
faster than non-selection sites. By mathematically quantifying deviations from the molecular clock under various 
selection scenarios, we demonstrate that the deviation from a constant clock becomes negligible as multiple escape 
lineages emerge. The most recent common ancestor of a virus pair from distinct escape lineages is most likely the 
transmitted founder virus, indicating that HIV-1 molecular dating is feasible even after the founder viruses are no 
longer detectable.
Conclusions: The ability of HIV-1 to escape from immune surveillance in many different directions is the driving force 
of molecular clock persistence. This finding advances our understanding of the robustness of HIV-1’s molecular clock 
under immune selection, implying the potential for molecular dating.
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Background
The molecular clock serves as a focal link between molec-
ular evolution at a microscopic level and species evolu-
tion at a macroscopic level [1, 2]. The molecular clock 
hypothesis has been examined in a wide range of spe-
cies both at the genomic and protein levels. Representa-
tive supporting data include (1) quantitative associations 
between amino acid sequence differences of homologous 
proteins and fossil-based divergence times of different 
organisms [3–5] and (2) linear relationships between the 
amount of nonsynonymous nucleotide substitutions and 
mammalian species divergence times [6].
Probing for an HIV-1 intrahost molecular clock is an 
important task because we can trace an infection back 
to transmission using sequences from a single time point 
if the molecular clock can be applied to an HIV-1 pop-
ulation within an infected individual. Accurately dat-
ing HIV-1 transmission is crucial for identifying risk 
behaviors that lead to transmission, monitoring preven-
tion efforts, and informing when each immune response 
develops and matures. Estimates on the timing of infec-
tion can help us define immune correlates for protection 
using data from HIV-1 vaccine and prevention trials; for 
instance, knowledge of the time of HIV-1 acquisition will 
Open Access
Retrovirology
*Correspondence:  hayoun@usc.edu 
†Sung Yong Park and Tanzy M. T. Love contributed equally to this work 
1 Department of Molecular Microbiology and Immunology, Keck School 
of Medicine, University of Southern California, 1450 Biggy Street, Los 
Angeles, CA 90089, USA
Full list of author information is available at the end of the article
Page 2 of 12Park et al. Retrovirology  (2016) 13:38 
be important in determining the antibody titer thresh-
old for protection in the Antibody Mediated Prevention 
(AMP) study [7]. Furthermore, the ability to molecu-
larly date the HIV-1 gene pool expands the opportunity 
to determine HIV-1 incidence using recently developed 
genomic assays [8, 9].
The hypothesis that HIV-1 evolves in a clock-like man-
ner has been tested; however, a consensus has not been 
reached. Rigorous statistical evaluations have been con-
ducted on a diverse array of HIV-1 sequence data of dif-
ferent genomic regions, revealing both clock-like and 
non-clock-like behaviors [10–15]. The molecular clock 
hypothesis, while its existence itself is controversial, has 
been widely applied to estimate phylogenies and branch-
ing times of HIV-1 inter-host and intra-host populations: 
strict or relaxed molecular clocks were used to (1) date 
the ancestor of the main group of HIV-1 [16–18], (2) 
reconstruct the spread dynamics of HIV-1, estimating 
the location and timing of early transmission [19], and 
(3) quantify the intra-host HIV-1 envelope diversifica-
tion rate in a range of 1.72× 10−5 per base per day to 
4.32× 10−5 per base per day [20–23].
The HIV-1 gene population within an infected indi-
vidual shows heavy selection signatures and fast-paced 
evolution due to a rapid turn-over rate and high muta-
tion rate. Following transmission, an HIV-1 population 
evolves through the interplay of random mutations and 
immune selection in a complex setting of population 
growth and decline before reaching a stable virus load. 
This dynamic phase is a period of heightened immune 
selection pressure, which commences an evolutionary 
arms race between the virus and the immune system. 
Around 1  month post infection, the first CD8+ T cell 
responses targeting the founder viruses lead to rapid viral 
escapes with amino acid changes in CD8+ T cell epitope 
sequences at a rate as fast as 0.42 per day [24, 25]. This 
rate implies that a minor mutant present in 5  % of the 
total viral population could become the dominant line-
age making up 95 % of the population in just 2 weeks. In 
the wake of the early CD8+ T cell responses, initial neu-
tralizing antibody responses develop at around 3 months 
post infection, resulting in an ongoing pattern of viral 
escape and antibody evolution [26–28]. Understanding 
the effect of strong immune selection on HIV-1’s molecu-
lar clock is of interest as selection is often thought to be a 
rate-changing factor [2, 29], driving a genealogy to depart 
from that of random evolution by placing preference for 
particular lineages and perturbing the molecular clock.
In this study, we empirically and theoretically examine 
evidence of molecular clock conservation under selec-
tion by combining gene sequence data with mathemati-
cal models for HIV-1 evolution. We analyzed previously 
published HIV-1 envelope gene sequences collected 
from within 1  month of infection with sample intervals 
of days and weeks and traced HIV evolution at the onset 
of immune selection. Our primary goal is to examine 
whether a selection-induced heterogeneous phylogeny 
can conform to a strict molecular clock. By mathemati-
cally quantifying deviations from the molecular clock in 
an array of selection scenarios, we define conditions for 
the existence of a molecular clock.
Results
We examined HIV-1 diversification patterns under 
immune selection from serial measures of HIV-1 enve-
lope gene sequence diversity. We analyzed 1587 previ-
ously published HIV-1 whole envelope gene sequences 
obtained serially from 15 acutely infected individuals [27, 
30–32]. Figure  1a plots HIV-1 envelope gene sequence 
diversity dynamics during the 150 days following the first 
sample. To avoid the uncertainty of when each subject’s 
first sample was taken, all subsequent data points are pre-
sented in terms of the increase in diversity and the time 
following the first sample.
A mixed effects model was used to analyze the 15 sub-
jects’ diversity dynamics over time (see “Methods”). At 
the population level, in the first 150  days following the 
first sample, the linear diversification of all 15 subjects’ 
HIV sequences was statistically significant (p  <  0.0001), 
while quadratic attenuation was not (p = 0.76) (Fig. 1a). 
At the individual level, each subject’s sequence popula-
tion showed statistically significant linear relationship 
(Table 1). This rate of linear diversification ranged from 
1.54 × 10−5 to 3.91× 10−5 per base per day with a pop-
ulation mean of 2.69 (±0.29) × 10−5 (Table 1), which is 
close to the HIV-1 diversification rate under the neutral 
evolution assumption (i.e. all HIV-1 infected cells pro-
duce the same number of secondary infected cells in a 
single replication cycle), 2.16× 10−5 per base per day 
[33–35]. This neutral evolution rate was approximated 
as 2ε/τ with the viral generation time τ = 2 days and 
HIV-1 single cycle base substitution rate ε = 2.16× 10−5 
per base per cycle [35]. We found that 12 out of the 15 
subjects’ rates of diversification matched the neutral 
evolution rate (Table  1). We did not observe any differ-
ences in the linear diversification rate between males and 
females (p = 0.70, ANOVA), contradicting a recent study 
that reported a greater evolution rate in risk groups with 
a higher proportion of men [36]. We then traced HIV-1 
diversity over a longer time frame of 2  years, as shown 
in Fig. 1b, a quadratic attenuation became significant at 
the population level (p = 0.028). Figure 2 plots each sub-
ject’s diversity dynamics over 2 years of infection with the 
best-fit of a mixed effect model (Additional file 1: Table 
S1). The quadratic leveling-off of diversity was signifi-
cant over 2 years in 4 of the 15 subjects, CH077, CH131, 
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CH159 and CH505 (see p values for each quadratic term 
in Additional file 1: Table S1). Our observation suggests 
that an intrahost HIV-1 population evolves in a clock-
like manner close to the error rate of HIV-1 reverse tran-
scriptase for the first 150  days following infection and 
starts to slowly level off afterwards. 
We next examined spatial patterns of mutations across 
the envelope gene. Figure 3a shows mutations away from 
the founder sequence along subject CH042’s envelope 
gene sequences; the locations of mutations are clustered 
on putative selection sites rather than randomly scat-
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Fig. 1 HIV-1 diversity dynamics of 15 subjects. a Diversity increase as a function of time for the first 150 days since the first sample for 15 HIV-1 
infected individuals, CAP045, CH040, CH042, CH058, CH077, CH131, CH159, CH162, CH164, CH185, CH198, CH256, CH505, SUMA0874 and 
WEAU0578. A total of 1587 HIV-1 full envelope gene sequences were obtained from references [27, 30–32]. The population dynamics showed a sta-
tistically significant linear diversification rate of 2.69 (±0.29) × 10−5 per site per day (p < 0.0001). The solid line represents the fit of the mixed effects 
model and the dotted line represents the neutral diversification rate, 2.16× 10−5 per site per day [33–35]. b Diversity dynamics over 2 years since 
the first sample of the 15 subjects. The solid curve denotes the best-fit of the mixed effects model to these overall dynamics. Over the 2 year time 
frame, the envelope gene sequence population diversifies linearly at a rate of 2.30× 10−5 per site per day (p < 0.0001) and quadratically at a rate of 
−0.00122× 10
−5 per site per day2 (p = 0.028). The dotted line again represents the neutral diversification rate, 2.16× 10−5 per site per day
Table 1 The rate of HIV-1 envelope gene sequence diversification with standard errors during the 150 days from the first 
sample in 15 subjects whose sequence data come from references [27, 30–32]
a Less than 0.05 implies a statistically significant deviation from the neutral evolution rate, 2.16 × 10−5 per site per day




p-value p-value for  
departure from the linear 
neutral ratea
Rate of diversification 
in selection sites  
(× 10−5 per base per day)
Rate of diversification  
in non-selection sites 
(× 10−5 per base per day)
CAP045 3.24 ± 0.56 <0.0001 0.073 8.74 ± 57.8 3.04 ± 0.50
CH040 1.54 ± 0.39 0.0013 0.13 47.3 ± 35.9 1.16 ± 0.35
CH042 1.96 ± 0.61 0.0061 0.74 28.2 ± 65.8 1.48 ± 0.55
CH058 2.91 ± 0.51 <0.0001 0.16 633.9 ± 50.6 2.03 ± 0.46
CH077 3.91 ± 0.42 <0.0001 0.00097 91.2 ± 39.8 3.09 ± 0.38
CH131 2.21 ± 0.38 <0.0001 0.90 27.1 ± 35.6 1.80 ± 0.34
CH159 2.57 ± 0.42 <0.0001 0.34 22.2 ± 39.4 2.21 ± 0.37
CH162 2.46 ± 0.53 0.0004 0.57 78.0 ± 53.2 1.89 ± 0.47
CH164 2.26 ± 0.64 0.0033 0.88 43.4 ± 71.9 1.83 ± 0.58
CH185 1.86 ± 0.57 0.0053 0.61 47.2 ± 59.0 1.51 ± 0.51
CH198 3.57 ± 0.62 <0.0001 0.039 50.4 ± 68.4 3.09 ± 0.56
CH256 3.58 ± 0.58 <0.0001 0.028 57.3 ± 61.0 2.77 ± 0.52
CH505 2.30 ± 0.27 <0.0001 0.60 45.4 ± 23.7 1.57 ± 0.24
SUMA0874 2.85 ± 0.78 0.0027 0.39 706.8 ± 109.8 2.17 ± 0.70
WEAU0578 3.17 ± 0.79 0.0013 0.22 190.8 ± 113.8 2.39 ± 0.71
Population 
mean
2.69 ± 0.29 N/A N/A 138.5 ± 61.7 2.13 ± 0.26
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susceptible to immune selection, and thus viral escapes 
via mutation in these 15 subjects [27, 30–32]. Experi-
mentally identifying all selection sites, however, was not 
feasible. Alternatively, a statistical approach can provide 
a comprehensive list of putative selection sites based on 
patterns in sequence samples. We defined putative selec-
tion sites as nucleotide positions showing more base 
substitutions from the founder nucleotide than would be 
expected to occur by chance in the absence of selection. 
To designate putative selection sites, we first measured 
the mutant frequency: the proportion of sequences at a 
given time that do not match the founder sequence at 
a particular nucleotide site. Figure  3b plots the mutant 
frequency distribution of all sites along 25 full enve-
lope gene sequences obtained from subject CH042 at 
676  days from the first sample date. In the absence of 
selection, the number of sequences, k, at a given time 
post infection, t, that do not match the founder sequence 
at a particular nucleotide site would follow a binominal 
distribution,
where NS is the number of sampled sequences, ε is the 
HIV-1 single cycle base substitution rate and τ is the 
viral generation time [20–23]. The best fit of the bino-
mial distribution to subject CH042’s mutant frequency 














distribution is presented by the dashed line in Fig.  3b. 
This fit defines a threshold mutant frequency such that 
sites exhibiting mutations from the founder sequence 
above the threshold mutant frequency are designated as 
putative selection sites.
Indeed, some statistically identified selection sites 
match experimentally confirmed peptides reactive to 
autologous CD8+ T cells, including VQKEYAFFYK 
(169–178) and QFRNKTIVF (gp160 352–361) [32]. Some 
of these selection sites we identified that are consistent 
with known CD8+ T cell epitopes are also restricted by 
the same HLA type for each individual. Additional file 1: 
Table S2 links, when applicable, each designated selec-
tion site to a known CD8+ T cell epitope in the Los Ala-
mos National Laboratory HIV-1 Molecular Immunology 
Database (http://www.hiv.lanl.gov/content/immunol-
ogy/maps/maps.html). On average, around 60  % of the 
statistically identified selection sites were located within 
known CD8 T cell epitope regions (Additional file  1: 
Table S1).
Clear immune selection signatures were visible when 
we compared diversity dynamics between selection 
and non-selection sites. Subject CH042’s sequence 
data showed that diversity increased more rapidly 
within designated selection sites than it did outside of 
them (Fig.  3d). The slope of the selection sites’ diver-
sity increase was around 19 times greater than that of 
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Fig. 2 Individual HIV-1 diversity dynamics. Each of the 15 subjects’ diversity dynamics as a function of time over 2 years since the first sample. The 
dotted line of each panel indicates the neutral diversification rate, 2.16× 10−5 per site per day [33–35], and the solid curve denotes the best-fit of the 
mixed effects model. All 15 subjects show a statistically significant linear increase in diversity over time; subjects CH077, CH131, CH159 and CH505’s 
quadratic increases are statistically significant. The linear diversification rate for the first 150 days of each individual is listed in Table 1 and the linear 
and quadratic diversification rates over 2 years are listed in Additional file 1: Table S1
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observed a similar pattern in subject CH256 (Fig. 3e) and 
all other subjects. Our mixed effects model estimated 
that, on average, selection sites diversify around 65 times 
more rapidly than non-selection sites during the first 
150 days post infection (Table 1). Finding the majority of 
base substitutions in sites which cover between 0.12 and 
3.14 % of the full envelope gene indicates that the capac-
ity to select viral variants is highly concentrated within 
immune targeted sites.
While patterns of multiple mutant forms were preva-
lent in selection sites, some sites become homogeneous 
after the first 150  days since infection; for example, in 
12 putative selection sites of subject CH131, the same 
single nucleotide replaced the founder nucleotide in 
all sequences at each respective site 670  days after the 
first sample date. In this subject, we observed a smaller 
increase in genetic diversity than predicted by the molec-
ular clock (Fig.  2) due to these homogeneous selection 
sites. Some selection sites were homogeneous in four 
other subjects, CAP045, CH077, CH185, and CH256, 
showing deviations from the constant evolution rate 
caused by decreased diversity, as shown in Fig. 2. None-
theless, hard sweep signatures are lacking within these 
five subjects because the frequency of heterogeneous 
selection sites remains substantial, ranging from 38.5 to 
75.5 %; in the other 10 subjects, the homogeneous sites 
make up fewer than 20 % of all identified putative selec-
tion sites. While homogeneity creates notable deviations 
from clock-like evolution after the first 150  days post 
infection, it is most commonly not the primary determi-
nant of HIV-1 selection patterns.
Next, we sought to understand the link between clock-
like evolution and clustered mutation at immune selec-
tion sites, which were simultaneously observed in a 
considerable number of envelope gene sequences from 
the 15 individuals. We developed a model of HIV-1 
gene evolution and within-host viral dynamics during 
the early phases of immune selection. As illustrated in 
Fig.  4a, in our model the founder lineage initially repli-
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Fig. 3 Diversity dynamics within selection sites and non-selection sites. a The highlighter plot (http://www.hiv.lanl.gov/content/sequence/
HIGHLIGHT/highlighter_top.html) of subject CH042’s envelope gene sequences obtained 676 days after the first sample, along with the founder 
envelope sequence (top). Here the founder envelope sequence was inferred as the consensus sequence of subject CH042’s first sample at Fiebig 
stage I/II. The subsequent sequences show positions of mutations away from the founder sequence. b The mutant frequency distribution for 
subject CH042 in Ref. [32] (grey bars). Mutant frequency denotes the proportion of sequences from a particular time point that do not match the 
founder sequence nucleotide at a given site. The dotted line presents the best fit of the binomial distribution in Eq. (1) to subject CH042’s mutant 
frequency distribution. The threshold value of mutant frequency is determined when the tail of the fitted curve becomes less than 0.1; sites above 
this threshold of 0.2 were designated as putative selection sites. A total of 63 putative selection sites were identified. c The mutant frequency dis-
tribution of subject CH256 in Ref. [32] (grey bars) along with the best fit of the binomial distribution (dotted line). The threshold mutant frequency is 
determined as 0.2, where the tail of the binomial distribution becomes less than 0.1. The 53 sites with a mutant frequency above the threshold were 
regarded as putative selection sites. d The diversity dynamics of selection sites (squares) compared with those within non-selection sites (asterisks) 
for subject CH042. The slope of diversity at selection sites is around 28.2× 10−5 per base per day, which is approximately 19 times greater than that 
of non-selection sites for the first 150 days after the first sample. The dotted line presents the neutral rate of evolution, 2.16× 10−5 per site per day. 
e The diversity dynamics of selection sites (squares) compared with those of non-selection sites (asterisks) for subject CH256. The slope of diversity 
increase at selection sites was around 21 times greater than that at non-selection sites (57.3× 10−5 vs. 2.77× 10−5 per base per day)
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secondary infected cells from a single infected cell [30, 
35]. Each replication cycle involves HIV-1 reverse tran-
scriptase-mediated base substitution errors with rate ε. 
Departing from neutral evolution, at the onset of selec-
tion, at generation gs1, a single infected cell harboring 
an escape virus is assumed to arise and begin producing 
R1 daughter cells, while the replicative capacity of the 
wild-type infected cells is significantly compromised due 
to immune recognition, producing only sR0 daughters 
on average, with 0  <  sR0  <  1. Thus, the selection coeffi-
cient of the wild-type virus relative to the escape mutant 
is S =  1 −  (sR0/R1). During the viral decline phase, the 
wild-type population is rapidly cleared by immune selec-
tion while the proportion of the mutant-type population 
increases within the total population, leading to viral 
escape. After the viral set point is reached (generation 
gs in Fig.  4a), all existing mutant-type infected cells are 
assumed to repopulate themselves without increasing the 
population size (R1 = 1). In this model, the total infected 
cell count and viral load, proportional to the former, 
mimic what is observed through the natural course of an 
HIV-1 infection—an exponential increase followed by a 
rapid decline, with a steady population level thereafter 
(Fig. 4b).
Despite modification of HIV-1 genealogy by immune 
selection, our model showed that any given wild-type 
virus pair most likely coalesces at the transmission point 
[Additional file  1: Eq. (S14)]. The genealogy of mutant-
type pairs followed a neutral evolution scenario wherein 
all mutant descendants originate from a single mutant 
ancestor. As shown in Fig. 4c, the coalescence probabil-
ity of the mutant-type pairs peaked when the first mutant 
virus appears and exponentially decreases afterwards 
[Additional file 1: Eq. (S17)]. Our calculation also showed 
that a wild-mutant virus pair most likely coalesces at the 
transmission point with the same trend as does a wild–
wild pair [Additional file  1: Eq. (S20)]. The most recent 
common ancestor (MRCA) for both wild–wild and wild-
mutant pairs was most likely the founder virus, whereas 
for mutant–mutant pairs it was most likely the first 
mutant virus. Therefore, the total population coalescence 
distribution depended on the ratio between the wild-type 
population and the mutant one. When the mutant popu-












































































Fig. 4 Modeling HIV-1 evolution under immune selection. a Schematic diagram of the HIV-1 selection model. The wild-type infected cell (black) 
produces R0 offspring up to generation gs1 and afterwards produces sR0 offspring due to immune selection (sR0 < 1). One mutant-type infected cell 
(red) starts to produce R1 secondary infected cells at generation gs1. At the viral set point (g ≥ gs) the reproductive ratio of the mutant-type infected 
cells becomes equal to 1. b The total HIV-1 infected cell population level (blue line) as a function of time post infection. The infected cell popula-
tion consists of the wild-type (black) and mutant-type infected cells (red). The model parameters are R0 = 6, sR0 = 0.78, R1 = 1.5, gs1 = 15 (30 days) 
and gs = 50 (100 days). The HIV-1 single cycle mutation rate is 2.16× 10−5 per base per generation [33] and the generation time is 2 days [34]. The 
wild-type infected cell population grows exponentially and starts to decline at the emergence of selection pressure, approximately 1 month post 
infection [24, 28]. Subsequently, a mutant-type infected cell arises and replicates exponentially. c The coalescent time distribution of wild–wild 
virus pairs (black bars) and mutant–mutant pairs (red bars). The coalescent time distribution of wild-mutant pairs is the same as that of wild–wild 
pairs (black bars). The wild–wild and wild-mutant pairs most likely coalesce at the transmission point, while the most recent common ancestor of 
a mutant-type virus pair is the mutant-founder virus that appears at generation gs1, i.e. 30 days post infection. When the wild-type virus population 
size is comparable with the mutant-type population size at 132 days post infection, the coalescent probability of any random viral pair including 
wild–wild, wild-mutant, and mutant–mutant pairs (blue bars) peaks at the transmission point (generation 0). d Diversity dynamics of the one-
mutant model (red line), two-mutant model (blue line), and neutral model (dotted black line). The model parameters for the two-mutant model are 
R0 = 6, sR0 = 0.78, R1 = 1.5, R2 = 1.5, gs1 = 15 (30 days), gs2 = 16 (32 days), and gs = 50 (100 days). The diversity dynamics of the two-mutant model 
more closely resemble the neutral model’s diversity dynamics than the one-mutant model’s
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coalescent profile peaked at the origin of an infection, as 
shown in Fig. 4c.
The coalescent profile of all virus pairs permits us to 
evaluate diversity dynamics, from which we can assess 
deviations from the molecular clock. The deviation from 
a constant molecular clock can be quantified as the dif-
ference between the sequence diversity and the reference 
neutral clock diversity. As detailed in Additional file  1, 
when the mutant population was prevalent at the viral set 
point, the clock deviation, 1, was approximated as
Here Eq.  (2) indicates that the clock deviation is mainly 
affected by the time that the escape lineage arises (gs1); 
the later it appears, the greater the deviation. The repli-
cative capacity of the mutant-type virus (R1) and wild-
type virus (R0) also contribute to the clock deviation. 
On the other hand, the deviation does not depend on 
the selective disadvantage of the wild-type population 
(s). Likewise, the clock deviation is approximately con-
stant regardless of when viruses are sampled (g) after the 
mutant lineage arises.
Our findings demonstrated that a fraction of selection 
sites showed an extreme level of diversity (Fig. 3), reveal-
ing the presence of multiple escape lineages. Accordingly, 
we generalized the model to more rigorously address 
how the clock deviation changes as more mutant lineages 
accrue. The generalized N-mutant model showed that all 
virus pairs except intra-mutant pairs (those within a sin-
gle mutant lineage), including wild–wild, wild-mutant, 
and inter-mutant pairs, most likely coalesce at the 
founder virus [see Additional file 1: Eqs. (S66), (S69), and 
(S72)]. The deviation from the molecular clock decreases 
as more distinct mutant lineages appear, approximated as 
the single mutant model deviation divided by the number 
of mutant lineages, N,
This calculation indicates complete molecular clock 
conservation in the large N limit. For instance, Fig.  4d 
shows that when two mutant viruses appear, the clock 
deviation becomes half of that of the single mutant 
model. The conservation of the molecular clock in a 
selection-induced heterogeneous phylogeny can be 
understood from our demonstration that distinct mutant 
lineages most probably coalesce at the origin of an 
infection. As more distinct mutant lineages appear, the 
proportion of virus pairs coalescing to the initial trans-
mission point increases within the total viral population, 
decreasing the deviation from the molecular clock. Ergo, 














eliminated from the viral population, this clock prop-
erty allows us to assess the time since infection based 
on sequences of escape mutant populations, permitting 
molecular dating of HIV-1 infections.
In the presence of multiple escape lineages, our model 
predicted that the most probable coalescent point of 
any two distinct mutant lineages would be the same as 
that of wild-type virus pairs: the transmission point. We 
tested this prediction by comparing the diversity among 
mutant-type pairs from distinct lineages and the diver-
sity among wild-type pairs. To clearly designate distinct 
mutant lineages, we selected four subjects whose enve-
lope sequences at a chosen time showed the signature of 
escape within only one epitope. Table 2 lists the CD8+ T 
cell epitope sequences of both founder and mutant line-
ages for each of these four cases. Here, the wild-type line-
age is designated in reference to the consensus sequence 
of the earliest time point sample of each individual. 
Each mutant lineage was grouped based on amino acid 
sequence variations within the CD8+ T cell epitopes. As 
in Table  2, more than one escape lineage derived from 
the same epitope existed in all four cases. As predicted by 
our model, the diversity among mutant-type pairs from 
distinct lineages and wild-type pairs are highly similar to 
one another (Fig. 5). Contrarily, the diversity within each 
Table 2 Founder and  escape lineages of  a given  epitope 
from each subject’s single time point sequence data
The sequence data from subject CH077, SUMA0874, and WEAU0575 are 
obtained from Ref. [30] and the sequence data from subject CH164 are 
obtained from Ref. [32]. The sample time point is 14, 56, 30, and 15 days after 
the first sample at Fiebig stage I/II for subject CH077, CH164, SUMA, and WEAU, 
respectively




 Founder-lineage 9 QFRNKTIVF
 Escape-mutant 1 38 QFKNKTIVF
 Escape-mutant 2 4 QFRNKAIVF
CH164 gp160 (2–10)
 Founder-lineage 5 RVMETRRSW
 Escape-mutant 1 10 RVMKTRRSW
 Escape-mutant 2 8 RVMGTRRSW
SUMA0874 gp160 (744–753)
 Founder-lineage 18 RSSRLVDGFL
 Escape-mutant 1 6 RSGRLVDGFL
 Escape-mutant 2 4 RSSCLVDGFL
WEAU0575 gp160 (31–39)
 Founder-lineage 24 AENLWVTVY
 Escape-mutant 1 18 AEKLWVTVY
 Escape-mutant 2 7 TENLWVTVY
 Escape-mutant 3 5 VENLWVTVY
 Escape-mutant 4 4 AKNLWVTVY
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mutant lineage is considerably smaller than that of the 
founder lineage (Fig. 5), which is in good agreement with 
the prediction that intra-mutant lineage pairs coalesce at 
a later generation than do wild-type lineage pairs.
Discussion
The present study examined the rate of HIV-1 enve-
lope gene diversification within 15 individuals who 
were serially surveyed from the acute stage of infec-
tion. HIV-1 sequence diversity increased linearly for 
the first 150  days of infection with a population mean 
of 2.69× 10−5 per base per day. This clock-like evolu-
tionary pattern showed variations in speed across the 
subjects, ranging from 1.54 × 10−5 to 3.91× 10−5 per 
base per day. This rate, estimated from comprehensive 
sequence data obtained by single genome amplification 
and Sanger sequencing, is comparable to previous esti-
mates of the intra-host HIV-1 nucleotide substitution 
rate, ranging from 1.72× 10−5 to 4.32× 10−5 per base 
per day [20–23]. While previous estimates were based 
on sequence data collected from either chronic infec-
tions or post seroconversion, our estimates are made 
using sequence data collected initially before immune 
selection and sampled with intervals of days and weeks. 
In this way, we were able to monitor the first HIV evo-
lution at the onset of immune selection. Understanding 
the molecular clock in these early phases is necessary to 
characterize transmission using a single time point sam-
ple. The rate of diversification for 12 of the 15 subjects 
was statistically comparable to the neutral evolution 
rate, 2.16× 10−5 per base per day, which was previously 
estimated based on HIV-1 single cycle mutation rate and 
viral generation time [30, 35]. Over 2 years of infection, 
HIV-1 diversification began to level off quadratically in 4 
of the 15 subjects.
We then investigated the spatial distribution of muta-
tions away from the transmitted/founder sequence across 
the envelope gene. Mutations were concentrated at puta-
tive selection sites, while HIV-1 sequence populations 
temporally diversify in a clock-like manner with rates 
consistent with the neutral evolution rate. We classified 
putative selection sites as positions that showed more 
base substitutions from the founder sequence than sta-
tistically expected. Around 60 % of the statistically iden-
tified selection sites were found to be in known CD8+ 
T cell epitopes from the Los Alamos Immune Database 
(http://www.hiv.lanl.gov). We then quantified the diver-
sity dynamics within the selection sites as compared to 
those within non-selection regions. On average, among 
the 15 subjects examined here, these viral escape sites 
diversify more than 65 times faster than do non-selection 
sites, indicating that the majority of mutations accumu-
late in immune selection sites spanning a small fraction 
of the entire envelope gene sequence.
Our observations emphasize the ability of multiple escape 
variants to arise from diverse amino acid changes at given 
selection sites, with ample evidence as presented in Table 2 
[24, 30]. There are several different mutational pathways 
through which HIV can escape from immune pressure. 
Viral escapes from cytotoxic T cell responses can be medi-
ated by non-synonymous mutations that can directly abro-
gate peptide-MHC binding [37, 38]. Escape can also occur 
via impaired recognition of viral peptide-MHC complexes 
by cytotoxic T cells [39, 40], or mutations that compromise 
intracellular epitope processing, for instance, by prevent-
ing NH2-terminal trimming of the epitope [41]. Antibody 
escape patterns are also heterogeneous; site-directed 
mutagenesis has identified multiple resistant variants 
within the viral envelope CD4 binding site [42]. A consid-
erable amount of sequence variation within the D, V1 and 
V5 loops, and the CD4-binding site of the HIV-1 envelope 
has been reported within a subject who developed broadly 
neutralizing antibody responses [27]. These diverse mecha-
nisms for avoiding immune surveillance sustain multiple 




















Fig. 5 Virus pair diversity comparisons. Diversity of wild–wild virus 
pairs (white bars), wild-mutant pairs (light grey bars), virus pairs from 
different mutant lineages (dark grey bars), and virus pairs from a 
single mutant lineage (black bars). The sequence data from subject 
CH077, SUMA0874, and WEAU0575 were obtained from Ref. [30] 
and the sequence data from subject CH164 were obtained from 
Ref. [32]. The sample time point is 14, 56, 30, and 15 days after the 
first sample at Fiebig stage I/II for subject CH077, CH164, SUMA, and 
WEAU, respectively. Table 2 lists wild and mutant epitope sequences 
of each subject at a given time point. For example, subject CH077’s 
sample 14 days after the first sample had one wild type lineage with 
the epitope QFRNKTIVF and two mutant lineages with either the 
epitope QFKNKTIVF or QFRNKAIVF. Here, the wild-type lineage was 
designated in reference to the consensus sequence of the first time 
point sequences of each individual. The full envelope gene sequence 
diversity of mutant-type pairs from distinct lineages was comparable 
to that of the wild-type lineage. As predicted by our model, the diver-
sity within each mutant lineage was considerably smaller than that 
of wild–wild pairs, wild-mutant pairs, and virus pairs from different 
mutant lineages (Wilcoxon–Mann–Whitney test, p = 0.067 for CH077, 
p = 0.067 for CH164, p = 0.067 for SUMA0874, and p = 0.00073 for 
WEAU0575)
Page 9 of 12Park et al. Retrovirology  (2016) 13:38 
To address how the molecular clock prevails in 
a dynamic environment that favors various escape 
mutants, we proposed a mathematical model describ-
ing HIV-1 replication and evolution after transmission. 
Our model approach allowed us to evaluate the devia-
tion from a constant molecular clock under different 
immune selection scenarios. When a mutant lineage 
arises from immune pressure, the most dominant factor 
of deviation from the clock was the timing of the escape 
mutant’s appearance; the later it appeared, the greater the 
deviation. Importantly, the clock deviation was inversely 
proportional to the number of distinct mutants; when 
more distinct mutant lineages appeared, viral evolution 
more closely resembled the molecular clock. This reduc-
tion in the clock deviation is due to the fact that distinct 
mutant lineages most likely coalesce at the founder virus, 
and thus the greater number of different mutant lineages 
increases the proportion of virus pairs coalescing to the 
initial transmission event within the total viral popula-
tion. Therefore, the capacity for HIV-1 to escape in mul-
tiple directions maintains the clock-like evolution of the 
overall HIV-1 intra-host population.
The presence of multiple mutant lineages can be 
linked to soft selective sweeps that occur when beneficial 
mutations are supplied at a rate equal to or greater than 
once per site per generation [43]. A chronically infected 
individual is expected to have around 108 productively 
infected CD4+ T cells [44]. At the peak of viremia dur-
ing acute infection, there will be an even greater num-
ber of productively infected cells, each being produced 
by one or more reverse transcription events. Thus, with 
the mutation rate of ε = 2.16× 10−5 per base per cycle 
[33, 35], each selection site is likely to have developed 
mutations desirable for viral escape before the onset of 
immune responses. The high mutation rate in parallel 
with the large HIV-1 population size renders the appear-
ance of multiple mutant lineages very probable, which 
ensures molecular clock persistence under selection. 
Similarly, in speciation events, genetic polymorphisms 
are presumably a major source of multiple mutant line-
ages in light of the much smaller mutation rate, around 
10−8 per base per generation [45].
There are several factors preventing complete adher-
ence to clock-like HIV-1 evolution. Recombination can 
alter coalescing patterns and thereby perturb clock-
like diversification [46]. Hypermutation mediated by 
APOBEC3G/F can cause the rejection of a single rate 
molecular clock [47]. Virus latency and compartmentali-
zation may result in viral lineages with different number 
of replication cycles since the founder virus, as compared 
to other lineages [48]. Linked homogeneous selection 
sites can also result in departures from the molecular 
clock; we observed that temporal deviations from the 
molecular clock were associated with a greater num-
ber of homogeneous selection sites. However, we did 
not observe hard sweep signatures even within subjects 
with homogeneity because the fraction of heterogeneous 
selection sites remained substantial, ranging from 38.5 
to 75.5  %. Immune selection patterns are characterized 
predominantly by soft sweeps, in contrast to HIV-1 drug 
resistance evolution which involves both hard and soft 
sweeps [43].
We observed subject-to-subject variations in the rate 
of early HIV diversification. As previously shown, one of 
the main parameters affecting the neutral evolution rate 
is the viral generation time [35]. There is considerable dif-
ference in the viral generation time, which is estimated 
from the slope of plasma HIV-1 RNA decline during 
antiretroviral therapy [34, 49–52]. However, the accu-
racy of estimates of viral generation time is complicated 
by a lack of knowledge of the in vivo drug efficacy in the 
patients under study. In addition to viral generation time, 
we may examine other individual-level factors that con-
tribute to variability in diversification rates. For instance, 
while a recent study observed a greater evolution rate in 
risk groups with a higher proportion of men [36], we did 
not observe any differences in the evolution rate between 
males and females.
The present study provides better opportunities for 
molecular dating of early HIV infections with a single 
time point sample. Our observation of clock-like evo-
lution under immune selection validates our approach 
of dating an early HIV infection using a patient’s Ham-
ming distance distribution [30, 35, 53]. Furthermore, 
the observed variability in the clock rates necessitates 
expanding the current method to model the popula-
tion variability, which could allow for greater precision 
in estimation of time since infection with a single time 
point sample. Additionally, the model should be applied 
to long-term infected individuals with precaution by con-
sidering the observed quadratic attenuation in the diver-
sity dynamics for a time frame over 2 years. Developing 
an accurate tool for estimating the timing of infection is 
required to meet the growing need for defining immune 
correlates for protection in on-going vaccine and preven-
tion trials [7].
Conclusions
In this study of HIV-1 intrahost evolution, we demon-
strated that a molecular clock can hold even when a gene 
phylogeny becomes increasingly complex as the popula-
tion evolves under selection. By tracing the evolution of 
HIV-1 at the onset of immune selection, we discovered 
that (1) 12 out of the 15 subjects’ evolution rate conform 
to the neutral evolution rate during the first 150  days 
post infection and (2) in contrast to this regular temporal 
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evolution pattern, mutations were highly clustered on 
selection sites that diversified more than 65 times faster 
than non-selection sites. Our mathematical model pro-
vides a link between clock conservation and multiple 
modes of HIV escape. HIV escape complexity was shown 
to ensure a constant clock-like diversification over time 
within the first 150  days of infection. The indication of 
a molecular clock functioning under heavy selection 
may allow us to date an HIV-1 gene population back to 
its transmission point, thereby providing crucial infor-
mation for HIV-1 prevention efforts and grounds for 
genome-based HIV incidence measures [8, 9].
Methods
Sources of published sequence data
A total of 1587 HIV-1 full envelope gene sequences were 
obtained from 15 subjects’ published data in references, 
[27, 30–32]. All subjects’ first samples were taken dur-
ing the acute stage of infection; the first sample of sub-
ject CH505 was estimated to have been obtained 4 weeks 
after infection and the first sample of the other 14 sub-
jects was obtained during Fiebig stage I/II. The sequences 
from subjects CAP045, CH042, CH131, CH159, CH162, 
CH164, CH185, CH198, CH256 and CH505 were sub-
type C and the sequences from subjects CH040, CH058, 
CH077, SUMA0874 and WEAU0578 were subtype B 
[27, 30–32]. The subjects did not receive antiretroviral 
therapy during the period that serial samples were taken 
[27, 30–32]. Serial HIV-1 envelope gene sequences from 
the other 11 subjects in these references were excluded 
in our analysis for the following reasons: subject CAP239 
had only two time point samples, subject CH607 received 
ART, subject CAP210 and CH470 showed the signature 
of more than a single founder variant, and subjects 1051, 
1056, 1058, 1059, 6247, CH607, and TT31P were fol-
lowed for a period of less than 1 month.
Mixed effect model for HIV-1 diversity dynamics
We used a linear mixed effects model to analyze the 
diversity increase over time from the first sample among 
the 15 subjects. Random coefficients were specified to 
allow for individual subject deviations from population 
average regression coefficients for linear and quadratic 
associations of diversity with time. A mixed effects model 
for HIV-1 intrahost diversity dynamics is written as,
where di(t) is subject i’s diversity increase at time t, meas-
ured in days, from the first sample, a+ ηi is the linear 
and b+ µi is the quadratic coefficient of subject i. Here, 
a is the population linear diversification rate and b is the 
population quadratic rate. Restricted maximum likeli-
hood was implemented in SAS Proc Mixed to estimate 
(4)di(t) = (a+ ηi)t + (b+ µi)t2,
and test the population average and random coefficients. 
Mixed model estimates were used to evaluate individual 
subject estimates of linear and quadratic diversity rates.
Authors’ contributions
SP, WJM, AP, and HL analyzed the sequence data and performed the statistical 
analyses. SP, TL and HL formulated the mathematical models. All authors read 
and approved the final manuscript.
Author details
1 Department of Molecular Microbiology and Immunology, Keck School 
of Medicine, University of Southern California, 1450 Biggy Street, Los Angeles, 
CA 90089, USA. 2 Department of Biostatistics and Computational Biology, 
University of Rochester, Rochester, NY 14642, USA. 3 Theoretical Biology 
and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA. 
4 Department of Preventive Medicine, Keck School of Medicine, University 
of Southern California, Los Angeles, CA 90089, USA. 
Acknowledgements
We thank Richard Neher and Su-Chan Park for helpful discussions and Nolan 
Goeken and Jason Kaufman for reviewing this manuscript.
Competing interests
The authors declare that they have no competing interests.
Funding
This work was supported by NIH Grants R01-AI083115 and R01-AI095066 
(HYL). Portions of this work were done under the auspices of the US Depart-
ment of Energy under Contract DE-AC52-06NA25396 and supported by NIH 
Grants R01-AI028433, R01-0D011095 and UM1-AI100645 (ASP).
Received: 22 February 2016   Accepted: 11 May 2016
References
 1. Kumar S. Molecular clocks: four decades of evolution. Nat Rev Genet. 
2005;6(8):654–62.
 2. Hedges SB, Kumar S. Discovering the timetree of life. In: Kumar S, Hedges 
SB, editors. The Timetree of life. New York: Oxford University Press; 2009. p. 
3–18.
 3. Margoliash E. Primary structure and evolution of cytochrome C. Proc Natl 
Acad Sci USA. 1963;50:672–9.
 4. Doolittle RF, Blomback B. Amino-acid sequence investigations of fibrin-
opeptides from various mammals—evolutionary implications. Nature. 
1964;202(492):147–52.
 5. Kumar S, Hedges SB. A molecular timescale for vertebrate evolution. 
Nature. 1998;392(6679):917–20.
 6. Kumar S, Subramanian S. Mutation rates in mammalian genomes. Proc 
Natl Acad Sci USA. 2002;99(2):803–8.
 7. http://ampstudy.org.
 8. Park SY, Love TM, Nelson J, Thurston SW, Perelson AS, Lee HY. Designing a 
genome-based HIV incidence assay with high sensitivity and specificity. 
AIDS. 2011;25(16):F13–9.
 9. Park SY, Goeken N, Lee HJ, Bolan R, Dube MP, Lee HY. Developing high-
throughput HIV incidence assay with pyrosequencing platform. J Virol. 
2014;88(5):2977–90.
Additional file
Additional file 1. Mathematical models for HIV evolution under immune 
selection, Table S1 (The rate of HIV gene sequence diversification over 
2 years from the first sample in 15 subjects), and Table S2 (Documented 
CD8+ T cell epitopes for statistically designated selection sites from 15 
subjects).
Page 11 of 12Park et al. Retrovirology  (2016) 13:38 
 10. Posada D, Crandall KA. Selecting models of nucleotide substitution: an 
application to human immunodeficiency virus 1 (HIV-1). Mol Biol Evol. 
2001;18(6):897–906.
 11. Gojobori T, Moriyama EN, Kimura M. Molecular clock of viral evolution, 
and the neutral theory. Proc Natl Acad Sci USA. 1990;87(24):10015–8.
 12. Leitner T, Albert J. The molecular clock of HIV-1 unveiled through 
analysis of a known transmission history. Proc Natl Acad Sci USA. 
1999;96(19):10752–7.
 13. Jenkins GM, Rambaut A, Pybus OG, Holmes EC. Rates of molecular 
evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol. 
2002;54(2):156–65.
 14. Salemi M. The intra-host evolutionary and population dynamics of 
human immunodeficiency virus type 1: a phylogenetic perspective. 
Infect Dis Rep. 2013;5(Suppl 1):e3.
 15. Lemey P, Rambaut A, Pybus OG. HIV evolutionary dynamics within and 
among hosts. AIDS Rev. 2006;8(3):125–40.
 16. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A, Hahn BH, 
Wolinsky S, Bhattacharya T. Timing the ancestor of the HIV-1 pandemic 
strains. Science. 2000;288(5472):1789–96.
 17. Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, Bunce 
M, Muyembe JJ, Kabongo JM, Kalengayi RM, Van Marck E, et al. Direct 
evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature. 
2008;455(7213):661–4.
 18. Salemi M, Strimmer K, Hall WW, Duffy M, Delaporte E, Mboup S, Peeters 
M, Vandamme AM. Dating the common ancestor of SIVcpz and HIV-1 
group M and the origin of HIV-1 subtypes using a new method to 
uncover clock-like molecular evolution. FASEB J. 2001;15(2):276–8.
 19. Faria NR, Rambaut A, Suchard MA, Baele G, Bedford T, Ward MJ, Tatem AJ, 
Sousa JD, Arinaminpathy N, Pepin J, et al. HIV epidemiology. The early 
spread and epidemic ignition of HIV-1 in human populations. Science. 
2014;346(6205):56–61.
 20. Edo-Matas D, Lemey P, Tom JA, Serna-Bolea C, van den Blink AE, van 
‘t Wout AB, Schuitemaker H, Suchard MA. Impact of CCR5delta32 
host genetic background and disease progression on HIV-1 intrahost 
evolutionary processes: efficient hypothesis testing through hierarchical 
phylogenetic models. Mol Biol Evol. 2011;28(5):1605–16.
 21. Maljkovic Berry I, Ribeiro R, Kothari M, Athreya G, Daniels M, Lee HY, Bruno 
W, Leitner T. Unequal evolutionary rates in the human immunodeficiency 
virus type 1 (HIV-1) pandemic: the evolutionary rate of HIV-1 slows down 
when the epidemic rate increases. J Virol. 2007;81(19):10625–35.
 22. Novitsky V, Wang R, Rossenkhan R, Moyo S, Essex M. Intra-host evolution-
ary rates in HIV-1C env and gag during primary infection. Infect Genet 
Evol. 2013;19:361–8.
 23. Lemey P, KosakovskyPond SL, Drummond AJ, Pybus OG, Shapiro B, Bar-
roso H, Taveira N, Rambaut A. Synonymous substitution rates predict HIV 
disease progression as a result of underlying replication dynamics. PLoS 
Comput Biol. 2007;3(2):e29.
 24. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov 
VV, Keele BF, Learn GH, Turnbull EL, Salazar MG, et al. The first T cell 
response to transmitted/founder virus contributes to the control of acute 
viremia in HIV-1 infection. J Exp Med. 2009;206(6):1253–72.
 25. Ganusov VV, Goonetilleke N, Liu MK, Ferrari G, Shaw GM, McMichael 
AJ, Borrow P, Korber BT, Perelson AS. Fitness costs and diversity of 
the cytotoxic T lymphocyte (CTL) response determine the rate of 
CTL escape during acute and chronic phases of HIV infection. J Virol. 
2011;85(20):10518–28.
 26. Richman DD, Wrin T, Little SJ, Petropoulos CJ. Rapid evolution of the 
neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci 
USA. 2003;100(7):4144–9.
 27. Liao HX, Lynch R, Zhou T, Gao F, Alam SM, Boyd SD, Fire AZ, Roskin KM, 
Schramm CA, Zhang Z, et al. Co-evolution of a broadly neutralizing HIV-1 
antibody and founder virus. Nature. 2013;496(7446):469–76.
 28. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The 
immune response during acute HIV-1 infection: clues for vaccine devel-
opment. Nat Rev Immunol. 2010;10(1):11–23.
 29. Margoliash E, Smith EL. Structure and functional aspects of cytochrome c 
in relation to evolution. In: Bryson V, Vogel HJ, editors. Evolving genes and 
proteins. New York: Academic Press; 1965. p. 221–42.
 30. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, 
Sun C, Grayson T, Wang S, Li H, et al. Identification and characterization of 
transmitted and early founder virus envelopes in primary HIV-1 infection. 
Proc Natl Acad Sci USA. 2008;105(21):7552–7.
 31. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker 
JM, Wang S, Baalwa J, Kraus MH, et al. Genetic identity, biological pheno-
type, and evolutionary pathways of transmitted/founder viruses in acute 
and early HIV-1 infection. J Exp Med. 2009;206(6):1273–89.
 32. Liu MK, Hawkins N, Ritchie AJ, Ganusov VV, Whale V, Brackenridge S, Li 
H, Pavlicek JW, Cai F, Rose-Abrahams M, et al. Vertical T cell immuno-
dominance and epitope entropy determine HIV-1 escape. J Clin Invest. 
2013;123(1):380–93.
 33. Mansky LM, Temin HM. Lower in vivo mutation rate of human immuno-
deficiency virus type 1 than that predicted from the fidelity of purified 
reverse transcriptase. J Virol. 1995;69(8):5087–94.
 34. Markowitz M, Louie M, Hurley A, Sun E, Di Mascio M, Perelson AS, Ho DD. 
A novel antiviral intervention results in more accurate assessment of 
human immunodeficiency virus type 1 replication dynamics and T-cell 
decay in vivo. J Virol. 2003;77(8):5037–8.
 35. Lee HY, Giorgi EE, Keele BF, Gaschen B, Athreya GS, Salazar-Gonzalez JF, 
Pham KT, Goepfert PA, Kilby JM, Saag MS, et al. Modeling sequence evolu-
tion in acute HIV-1 infection. J Theor Biol. 2009;261(2):341–60.
 36. Vrancken B, Baele G, Vandamme AM, van Laethem K, Suchard MA, Lemey 
P. Disentangling the impact of within-host evolution and transmission 
dynamics on the tempo of HIV-1 evolution. AIDS. 2015;29(12):1549–56.
 37. Carlson JM, Le AQ, Shahid A, Brumme ZL. HIV-1 adaptation to HLA: 
a window into virus-host immune interactions. Trends Microbiol. 
2015;23(4):212–24.
 38. Bronke C, Almeida CA, McKinnon E, Roberts SG, Keane NM, Chopra 
A, Carlson JM, Heckerman D, Mallal S, John M. HIV escape mutations 
occur preferentially at HLA-binding sites of CD8 T-cell epitopes. AIDS. 
2013;27(6):899–905.
 39. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi 
AO, Elvin JG, Rothbard JA, Bangham CR, Rizza CR, et al. Human immu-
nodeficiency virus genetic variation that can escape cytotoxic T cell 
recognition. Nature. 1991;354(6353):453–9.
 40. Iglesias MC, Almeida JR, Fastenackels S, van Bockel DJ, Hashimoto M, 
Venturi V, Gostick E, Urrutia A, Wooldridge L, Clement M, et al. Escape 
from highly effective public CD8+ T-cell clonotypes by HIV. Blood. 
2011;118(8):2138–49.
 41. Draenert R, Le Gall S, Pfafferott KJ, Leslie AJ, Chetty P, Brander C, Holmes 
EC, Chang SC, Feeney ME, Addo MM, et al. Immune selection for altered 
antigen processing leads to cytotoxic T lymphocyte escape in chronic 
HIV-1 infection. J Exp Med. 2004;199(7):905–15.
 42. Dreja H, Pade C, Chen L, McKnight A. CD4 binding site broadly 
neutralizing antibody selection of HIV-1 escape mutants. J Gen Virol. 
2015;96(7):1899–905.
 43. Pennings PS, Kryazhimskiy S, Wakeley J. Loss and recovery of 
genetic diversity in adapting populations of HIV. PLoS Genet. 
2014;10(1):e1004000.
 44. Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, Melroe H, Cavert 
W, Gebhard K, Staskus K, Zhang ZQ, et al. Quantitative image analysis of 
HIV-1 infection in lymphoid tissue. Science. 1996;274(5289):985–9.
 45. Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, Shannon PT, Rowen 
L, Pant KP, Goodman N, Bamshad M, et al. Analysis of genetic inherit-
ance in a family quartet by whole-genome sequencing. Science. 
2010;328(5978):636–9.
 46. Posada D. Unveiling the molecular clock in the presence of recombina-
tion. Mol Biol Evol. 2001;18(10):1976–8.
 47. Simon V, Zennou V, Murray D, Huang Y, Ho DD, Bieniasz PD. Natural vari-
ation in Vif: differential impact on APOBEC3G/3F and a potential role in 
HIV-1 diversification. PLoS Pathog. 2005;1(1):0020–8.
 48. Liu Y, Nickle DC, Shriner D, Jensen MA, Learn GH Jr, Mittler JE, Mullins JI. 
Molecular clock-like evolution of human immunodeficiency virus type 1. 
Virology. 2004;329(1):101–8.
 49. Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz 
M, Ho DD. Decay characteristics of HIV-1-infected compartments during 
combination therapy. Nature. 1997;387(6629):188–91.
 50. Kilby JM, Lee HY, Hazelwood JD, Bansal A, Bucy RP, Saag MS, Shaw GM, 
Acosta EP, Johnson VA, Perelson AS, et al. Treatment response in acute/
early infection versus advanced AIDS: equivalent first and second phases 
of HIV RNA decline. AIDS. 2008;22(8):957–62.
Page 12 of 12Park et al. Retrovirology  (2016) 13:38 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 51. Notermans DW, Goudsmit J, Danner SA, de Wolf F, Perelson AS, Mittler 
J. Rate of HIV-1 decline following antiretroviral therapy is related to viral 
load at baseline and drug regimen. AIDS. 1998;12(12):1483–90.
 52. Louie M, Hogan C, Hurley A, Simon V, Chung C, Padte N, Lamy P, Flaherty 
J, Coakley D, Di Mascio M, et al. Determining the antiviral activity of 
tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-in-
fected individuals. AIDS. 2003;17(8):1151–6.
 53. Love TM, Park SY, Giorgi EE, Mack WJ, Perelson AS, Lee HY. SPMM: estimat-
ing infection duration of multivariant HIV-1 infections. Bioinformatics. 
2016;32(9):1308–15.
